Suppr超能文献

高迁移率族蛋白 B1 水平可能与白塞病的疾病活动有关。

High mobility group box-1 levels may be associated with disease activity of Behcet's disease.

机构信息

Department of Internal Medical Sciences, Faculty of Medicine, Ankara University, Ankara, Turkey.

Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine,Ankara University, Ankara, Turkey.

出版信息

Turk J Med Sci. 2021 Oct;51(5):2690-2697. doi: 10.3906/sag-2101-116. Epub 2021 Oct 21.

Abstract

BACKGROUND

High mobility group box- 1 (HMGB- 1) is a nuclear protein acting as a proinflammatory molecule. The serum HMGB- 1 levels were found elevated in chronic inflammatory diseases. In this cross-sectional study, serum HMGB- 1 levels in Behcet's disease (BD) patients and healthy controls (HC) were studied. Also, its association with disease activity scores and clinical findings were evaluated.

METHODS

Ninety BD patients and 50 age-sex matched HC were included in the study. Disease activity scores were assessed by Behcet Disease Current Activity Form (BDCAF) and Behcet Syndrome Activity Score (BSAS). Serum HMGB- 1 levels were measured using a commercial ELISA kit. A p value of < 0.05 was considered to be statistically significant.

RESULTS

Serum HMGB- 1 levels were significantly higher in BD than in HC (43.26 pg/mL and 16.73 pg/mL; p < 0.001, respectively). Serum HMGB- 1 levels were statistically significantly associated with presence of erythema nodosum (EN) and genital ulcers in the last one month prior to recruitment (p = 0.041 and p < 0.001, respectively). BDCAF and BSAS scores were positively correlated with serum HMGB- 1 level ( p = 0.03 and p = 0.02, respectively).

DISCUSSION

HMGB - 1 may play a role in the development of BD. Also, due to its positive correlation with disease activity indices, it can be used as a novel disease activity parameter in BD.

摘要

背景

高迁移率族蛋白 B1(HMGB-1)是一种核蛋白,作为一种促炎分子。在慢性炎症性疾病中发现血清 HMGB-1 水平升高。在这项横断面研究中,研究了 Behcet 病(BD)患者和健康对照者(HC)的血清 HMGB-1 水平,并评估了其与疾病活动评分和临床发现的关系。

方法

纳入 90 例 BD 患者和 50 例年龄性别匹配的 HC。采用 Behcet 疾病活动表(BDCAF)和 Behcet 综合征活动评分(BSAS)评估疾病活动评分。使用商业 ELISA 试剂盒测量血清 HMGB-1 水平。p 值<0.05 被认为具有统计学意义。

结果

BD 患者血清 HMGB-1 水平明显高于 HC(分别为 43.26 pg/ml 和 16.73 pg/ml;p<0.001)。血清 HMGB-1 水平与招募前一个月内存在结节性红斑(EN)和生殖器溃疡呈统计学显著相关(p=0.041 和 p<0.001,分别)。BDCAF 和 BSAS 评分与血清 HMGB-1 水平呈正相关(p=0.03 和 p=0.02,分别)。

讨论

HMGB-1 可能在 BD 的发病机制中起作用。此外,由于其与疾病活动指数呈正相关,因此可作为 BD 的新型疾病活动参数。

相似文献

1
High mobility group box-1 levels may be associated with disease activity of Behcet's disease.
Turk J Med Sci. 2021 Oct;51(5):2690-2697. doi: 10.3906/sag-2101-116. Epub 2021 Oct 21.
2
Lack of association between serum IL-9 levels and Behçet's disease.
Immunol Lett. 2019 Jul;211:23-27. doi: 10.1016/j.imlet.2019.05.007. Epub 2019 May 13.
6
High mobility group box 1 serum levels are increased in Behçet's disease, but not associated with disease activity or disease manifestations.
Rheumatology (Oxford). 2015 Dec;54(12):2151-5. doi: 10.1093/rheumatology/kev202. Epub 2015 Jul 12.
7
Increased serum interleukin-32 levels in patients with Behçet's disease.
Int J Rheum Dis. 2018 Dec;21(12):2167-2174. doi: 10.1111/1756-185X.13072. Epub 2017 Apr 5.
9
An evaluation of depression, anxiety and fatigue in patients with Behçet's disease.
Int J Rheum Dis. 2019 Jun;22(6):974-979. doi: 10.1111/1756-185X.13411. Epub 2018 Nov 5.
10
Interleukin-17 mRNA expression and serum levels in Behçet's disease.
Cytokine. 2020 Mar;127:154994. doi: 10.1016/j.cyto.2020.154994. Epub 2020 Jan 14.

引用本文的文献

1
Research progress on the mechanism of exosome-mediated virus infection.
Front Cell Infect Microbiol. 2024 Jun 26;14:1418168. doi: 10.3389/fcimb.2024.1418168. eCollection 2024.

本文引用的文献

1
Alarmins in Osteoporosis, RAGE, IL-1, and IL-33 Pathways: A Literature Review.
Medicina (Kaunas). 2020 Mar 19;56(3):138. doi: 10.3390/medicina56030138.
2
Osteoporosis: Current and Emerging Therapies Targeted to Immunological Checkpoints.
Curr Med Chem. 2020;27(37):6356-6372. doi: 10.2174/0929867326666190730113123.
3
Behçet's disease.
Int J Rheum Dis. 2018 Dec;21(12):2057-2058. doi: 10.1111/1756-185X.13465.
4
Vascular Behçet's syndrome: an update.
Intern Emerg Med. 2019 Aug;14(5):645-652. doi: 10.1007/s11739-018-1991-y. Epub 2018 Nov 29.
5
Increased serum interleukin-32 levels in patients with Behçet's disease.
Int J Rheum Dis. 2018 Dec;21(12):2167-2174. doi: 10.1111/1756-185X.13072. Epub 2017 Apr 5.
8
Circulating HMGB1 and RAGE as Clinical Biomarkers in Malignant and Autoimmune Diseases.
Diagnostics (Basel). 2015 Jun 16;5(2):219-53. doi: 10.3390/diagnostics5020219.
9
High mobility group box 1 serum levels are increased in Behçet's disease, but not associated with disease activity or disease manifestations.
Rheumatology (Oxford). 2015 Dec;54(12):2151-5. doi: 10.1093/rheumatology/kev202. Epub 2015 Jul 12.
10
The role of high mobility group box 1 in innate immunity.
Yonsei Med J. 2014 Sep;55(5):1165-76. doi: 10.3349/ymj.2014.55.5.1165.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验